Basilea announces partial repurchase offer for at least CHF 90 million and up to CHF 110 million in principal amount of its outstanding convertible bonds due 2022

Brenda Snow
Authentic Patient Voice

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access